Ltd. (the "Company") announced that the Company and HBM Holdings Limited ("Harbour BioMed") (together with the Company, the "Licensors"), have entered into an exclusive license agreement (the ...

Mativ (MATV) and Chasm Advanced Materials have announced an exclusive licensing agreement. CHASM’s AgeNT Silver Nanowire and Carbon Nanotube hybrid performance film technology will be licensed ...

Ltd. (the “Company”) announced that the Company and HBM Holdings Limited (“Harbour BioMed”) (together with the Company, the “Licensors”), have entered into an exclusive license agreement (the “License ...

Merck (MRK) announced the closing of the exclusive global license agreement for LM-299, a novel investigational PD-1/VEGF bispecific antibody, from LaNova Medicines. As previously announced ...

Arecor Therapeutics has entered into an exclusive licensing agreement for AT351, a ready-to-dilute liquid formulation of a critical care therapy, with a major chemicals marketing company’s ...

In addition to perpetual exclusivity, the license agreement includes unlimited sales channel access, exclusive access to new formulations and expansion of the Cataclean brand’s reach into Mexico.

8, 2025 /PRNewswire/ -- 1cBio, Inc. (“1cBio”) an emerging biotech company developing precision medicines for significant unmet needs, and Alesta Pharmaceuticals (“Alesta”) a leader in developing first ...

On December 12, the company announced that its longstanding exclusive global licensing agreement with CBS News has been renewed. The multi-year contract strengthens Veritone’s role as a leading ...

Exclusive rights secured related to potential disease-modifying therapeutic for cardiovascular disease. Under the terms, Xentria will have an exclusive worldwide license to use NYU’s intellectual ...

(RTTNews) - Merck & Co., Inc. (MRK), Wednesday announced that the company has entered into an exclusive global license deal with China-based Hansoh Pharma to develop, manufacture and commercialize ...

Alongside this exclusive use agreement, the licensing agreement provides NOVONIX the right to an exclusive license to Harper’s technology on which its continuous graphitization furnaces operate.